News - Hadean Ventures

Neuro Event Labs Oy raises €2.0M investment for commercial expansion in Europe and US market entry of its AI-powered seizure detection device for epilepsy.

Tampere, Finland – 12 February 2025: Neuro Event Labs Oy today announced it has raised…

Great news from Neuro Event Labs Oy, as Nelli®, their AI-powered seizure detection and characterization…

TargED Biopharmaceuticals doses first participant in Phase 1 clinical trial of TGD001, a groundbreaking thrombolytic…

VALENCIA, Spain, Oct. 18, 2024 /PRNewswire/ — ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on…

Transition into clinical-stage development marks a significant corporate and R&D milestone. Munich, Germany, October 17,…

Step Pharma, the world leader in CTPS1 inhibition for the targeted treatment of cancer, today…

Alex Therapeutics has signed an exclusive agreement with Navamedic for the development of a Companion…

Attgeno AB today announces positive data from the company’s Phase IIa study, evaluating the effects…

Oncoinvent Receives FDA Fast Track Designation for Radspherin® as Treatment for Peritoneal Carcinomatosis from Ovarian…

Novo Nordisk to acquire Cardior Pharmaceuticals and strengthen pipeline in cardiovascular disease Bagsværd, Denmark, and…